Price $75.26 |
Market Cap
9.62B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
21.2
|
P/B
2.82
|
P/S
0.78
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
23.8
|
Op. Cash Flow
536K
|
FCF
3.1
|
|
Op. Margin
5.40%
|
Net Margin
3.80%
|
ROE
13.50%
|
ROI
12.60%
|
|
ROA
5.60%
|
EPS Growth
-23.90%
|
Current Ratio
1.8
|
Debt/Equity
30.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| LAVA Therapeutics NV (LVTX) | $2.24 | - | - | 49.9M | Strong Buy |
| Palatin Technologies, Inc. (PTN) | $2.28 | - | - | 26.2M | Strong Buy |
| Collegium Pharmaceutical Inc (COLL) | $21.38 | - | - | 773.2M | Strong Buy |
| Paratek Pharmaceuticals Inc (PRTK) | $2.17 | - | - | 106.5M | Strong Buy |
| PAVmed Inc (PAVM) | $0.46 | - | - | 44.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
